Skip to content

Alkermes ALKS Shares (Basic)

Shares (Basic) at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
61.9M+1.5%
AbbVie logo
AbbVieABBV
1.8B+0.1%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
51.2M+4.8%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
164.9M+3.9%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
100.5M+0.8%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM

Other financials

Income statement

See full
Revenue$392.9M+28.2%
Gross profit$331.3M+28.8%
Operating income-$48.3M-450%
Net income-$66.5M-396%
EPS (diluted)-$0.40-408%

Balance sheet

See full
Cash & equivalents$351.6M-12.1%
Total debt$1.6B+2,034%
Total equity$1.8B+15.9%
Total assets$4.3B+105%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$4.1M-59.5%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$7.5B+9.7%
Enterprise value$8.73B+41.2%
P/E49.1×+29.7×
P/S4.8×+0.3×

Profitability

See full
Gross margin86.6%+2.2pp
Operating margin12.3%-13.6pp
Net margin9.8%-13.5pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity9.4%-16.1pp
Debt / equity0.9×+0.9×
Current ratio2.3×-1.1×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Alkermes’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alkermes's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alkermes's shares (basic)?
Alkermes (ALKS) reported shares (basic) of 166.2M in Q1 2026.
How has Alkermes's shares (basic) changed year-over-year?
Alkermes's shares (basic) increased by 1.7% year-over-year, from 163.4M to 166.2M.
What is the long-term trend for Alkermes's shares (basic)?
Over 3 years (2022 to 2025), Alkermes's shares (basic) has grown at a 0.2% compound annual growth rate (CAGR), from 654.3M to 658.2M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.